It is well known that NF-κB plays a critical role in inflammation and is a transcription factor for a number of immune-related genes (IL-6, CCL2, among others) involved in immune responses; thus, it plays a dual role in promoting and inhibiting cancer (53). This evidence concerns the gene CCL2 and cancer.